THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
发明人:
NGAI, Ming-Yu,LEE, Katarzyna, N.,HU, Kongzhen,NASDEV, Neil,HAGGARTY, Stephen, J.
申请号:
USUS2018/013446
公开号:
WO2018/132636A1
申请日:
2018.01.12
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a compound having the structure: (Formula I), and a method of inhibiting Glycogen synthase kinase-3 β (GSK-3β) in a subject comprising administering to the subject said compound, so as to thereby inhibit the GSK-3β in the subject.La présente invention concerne un composé ayant la structure : (formule I) et un procédé d'inhibition de la glycogène synthase kinase-3 β (GSK-3β) chez un sujet, comprenant l'administration au sujet ledit composé, de manière à inhiber ainsi la GSK-3β chez le sujet.